Treatments | UNI-ASIA Cancer Hospital

The Cancer Center of Chengdu UNI-ASIA Hospital is dedicated to providing patients with comprehensive cancer medical services, covering prevention, screening, diagnosis, treatment, and rehabilitation support. The center adopts a multidisciplinary integrated diagnosis and treatment model, combining advanced minimally invasive oncology technologies with personalized treatment plans to provide full-process disease treatment services for every patient who comes to the hospital, meeting the needs of patients and people at risk of cancer.

Cancer is a complex disease that requires personalized care and treatment plans. UNI-ASIA Cancer Hospital is committed to continuously improving cancer prevention and care capabilities, enhancing treatment quality, and providing targeted, safe, world-class precision treatment solutions for patients worldwide.

Our Core Technologies

Transarterial Chemoembolization (TACE)

It is primarily used for the palliative treatment of intermediate to advanced-stage primary liver cancer, liver metastases, and hypervascular tumors in areas such as the head, neck, and lungs. It can also be used as postoperative adjuvant chemotherapy to help reduce the risk of local recurrence.

NanoKnife Ablation Technology

It is primarily indicated for solid tumors located in anatomically complex regions adjacent to major blood vessels, bile ducts, pancreatic ducts, the intestines, or nerves—such as locally advanced pancreatic cancer, hilar hepatic tumors, renal hilar tumors, and prostate cancer. This technique offers a safe and effective option for curative or cytoreductive treatment in patients with unresectable lesions or tumors unsuitable for conventional thermal ablation.

Iodine-125 Seed Implantation Technology

It is primarily indicated for solid tumors that are unresectable, recurrent, or metastatic after radiotherapy and chemotherapy, including primary liver cancer, non-small cell lung cancer, prostate cancer, and pancreatic cancer, as well as recurrent or metastatic tumors of the head and neck and pelvic regions.

Argon-Helium Knife Ablation Therapy

It is widely used in the treatment of liver cancer, lung cancer, renal cancer, as well as bone and soft tissue tumors. The technique is particularly suitable for lesions adjacent to the thoracic or abdominal wall, adrenal glands, and multiple metastatic tumors, making it an important component of the minimally invasive ablation system for solid tumors.

Radiofrequency Ablation Therapy

It is indicated for solid tumors such as solitary or multiple liver cancers and liver metastases measuring ≤5 cm in diameter, primary and metastatic lung cancers, renal cancers, and osteoid osteomas. For unresectable or recurrent tumors, it can also serve as an important palliative cytoreductive strategy to prolong survival.

Microwave Ablation Therapy

It is widely used in the treatment of liver cancer, liver metastases, lung cancer, adrenal tumors, and other solid malignancies. The technique is particularly advantageous for hypervascular tumors larger than 3 cm in diameter or those located adjacent to major blood vessels. It is also commonly combined with vascular interventional therapies and immunotherapy to achieve enhanced therapeutic outcomes.

Stent Placement

It is widely used for the palliative treatment of malignant luminal obstructions, including dysphagia caused by esophageal cancer, obstructive jaundice due to malignant biliary obstruction, dyspnea resulting from tracheal stenosis, malignant colorectal obstruction, and superior vena cava syndrome.

Percutaneous Vertebroplasty

It is a cornerstone approach for maintaining spinal stability and improving quality of life in various conditions, including vertebral metastases, multiple myeloma with vertebral involvement, aggressive vertebral hemangiomas, and painful osteoporotic vertebral compression fractures.

Chemotherapy combined with Targeted Therapy and Immunotherapy

It is widely used across various common solid tumors—including non-small cell lung cancer, hepatocellular carcinoma, esophageal cancer, gastric cancer, colorectal cancer, and breast cancer—in the first-line, adjuvant, and neoadjuvant settings, consistently improving survival and quality of life.

Why Choose Us?

A top-level system for cancer prevention, diagnosis, and treatment

Authoritative Experts

We bring together senior experts in China's oncology minimally invasive intervention and radiotherapy fields, each with more than 40 years of clinical experience. Having led interventional departments at China's top hospitals, they draw on experience from nearly 1,000,000 surgeries to build an internationally advanced minimally invasive treatment system.

Precision Diagnosis

We integrate cutting-edge minimally invasive technologies with molecular pathology testing to deeply examine tumor-cell target sensitivity and immune pathway characteristics, creating a clear evidence-based path for subsequent treatment.

Personalized Treatment

Based on tumor size, location, stage, and each patient's physical and psychological condition, we provide comprehensive personalized plans that combine interventional minimally invasive therapy, chemotherapy, radiotherapy, targeted therapy, and immunotherapy for coordinated treatment.

Multidisciplinary Treatment Team (MDT)

Building a care network through seamless collaboration

Minimally invasive oncology specialists, pathologists, radiologists, laboratory experts, and clinical pharmacists each contribute their expertise to develop optimal diagnosis and treatment strategies for patients. Pathologists use fine-needle aspiration techniques to reveal pathology with precision, while the multidisciplinary team pools insight to tailor recommendations and examination plans for every patient.

Details

Cancer Treatment Center

Consultation